MODIFICATION GENETIQUE DE CELLULES ENDOTHELIALES

History

What the Federal Institute of Intellectual Property published about this title, newest first.

1. May 19, 2010

   Deleted, fee unpaid

   Published in Swissreg on 19.05.2010

2. Jul 15, 1998

   Address changed

   Owner

   HOWARD HUGHES MEDICAL INSTITUTE, 6701 Rockledge Drive, Bethesda, MD 20817, USA, WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH, Nine Cambridge Center, Cambridge, MA 02142, USA, BRIGHAM & WOMEN'S HOSPITAL, 75 Francis Street, Boston, MA 02115, USA, NEW ENGLAND MEDICAL CENTER, HOSPITALS, INC., 750 Washington Street, Boston, MA 02111, USA, CELL GENESYS, INC., 322 Lakeside Drive, Foster City, CA 94404, USA → WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH, Nine Cambridge Center, Cambridge, MA 02142, USA, BRIGHAM & WOMEN'S HOSPITAL, 75 Francis Street, Boston, MA 02115, USA, NEW ENGLAND MEDICAL CENTER, HOSPITALS, INC., 750 Washington Street, Boston, MA 02111, USA, CELL GENESYS, INC., 322 Lakeside Drive, Foster City, CA 94404, USA, Howard Hughes Medical Institute, 4000 Jones Bridge Road, Chevy Chase/MD 20815, USA

   Published in PIDTJ No 13 in 1998

3. Jun 30, 1998

   Agent entered

   Representative

   Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich

   Published in PIDTJ No 12 in 1998

4. Feb 13, 1998

   Granted

   Published in PIDTJ No 3 in 1998

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.